Shenzhen University-Haoshi Cell Therapy Institute

Shenzhen University-Haoshi Cell Therapy Institute is a specialized biotechnology organization established through a strategic partnership between Shenzhen University and Shenzhen Haoshi Cell Therapy Co., Ltd. The institute focuses on the research, development, and clinical translation of advanced cell-based immunotherapies, particularly for oncology and regenerative medicine. Its core research programs include chimeric antigen receptor T-cell (CAR-T) therapies, natural killer (NK) cell platforms, and mesenchymal stem cell (MSC) applications. By integrating the academic research capabilities of Shenzhen University's Health Science Center with industrial-scale manufacturing, the institute aims to accelerate the development of personalized medicine. The organization is active in conducting investigator-initiated trials (IITs) to validate its therapeutic candidates in clinical settings.